
- ONCOLOGY Vol 14 No 7
- Volume 14
- Issue 7
House Republicans Block Physician Negotiating Bill
The House Rules Committee took the somewhat unusual step of blocking a key physician-backed bill from coming to the House floor for a vote. Late at night on May 24, the Committee voted to keep H.R. 1304 from coming to a vote on the House
The House Rules Committee took the somewhat unusual step of blocking a key physician-backed bill from coming to the House floor for a vote. Late at night on May 24, the Committee voted to keep H.R. 1304 from coming to a vote on the House floor. H.R. 1304 is the bill sponsored by Rep. Tom Campbell (R-CA) that would allow independent, private practice physicians in a given area to negotiate collectively with the managed care plans that operate in the area. This practice is currently illegal under antitrust laws. The House Judiciary Committee passed H.R. 1304 overwhelmingly by a vote of 26-2. After that committee vote, House Speaker Dennis Hastert (R-IL) promised Campbell that H.R. 1304 would soon come up for a House floor vote. But the health insurance industry strongly opposes the bill, and it apparently was able to get the ear of members of the House Rules Committee, who are responsible for clearing bills for House floor votes. The American Medical Association (AMA), which has led a coalition of physician groups, was outraged by the Rules Committee action. D. Ted Lewers, md, chair of the AMA Board of Trustees, says, It is hard to imagine a more outrageous subversion of the American democratic process. How can a Rules Committeeselected by the Speaker of the Housepull from floor consideration a bill that has the support of more than a majority of the House of Representatives?
Articles in this issue
about 25 years ago
Non–Small-Cell Lung Cancer Single-Agent Therapyabout 25 years ago
Linezolid-A New Option for Treating Gram-Positive Infectionsabout 25 years ago
Current Issues in the Treatment of Resistant Bloodstream Infectionsabout 25 years ago
Changing Patterns of Infections and Antimicrobial Susceptibilitiesabout 25 years ago
Ambulatory Antimicrobial Therapy for Hematologic Malignanciesover 25 years ago
Questions and Answers: Non–Small-Cell Lung Cancerover 25 years ago
Questions and Answers: Small-Cell Lung Cancerover 25 years ago
Irinotecan in Small-Cell Lung Cancer-Japanese TrialsNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.



















































































